Jingrong Cao

Person

Newton, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibitors of APOL1 and methods of using same
- Patent number 12,116,343
- Issue date Oct 15, 2024
- Vertex Pharmaceuticals Incorporated
- Leslie A. Dakin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of APOL1 and methods of using same
- Patent number 12,060,346
- Issue date Aug 13, 2024
- Vertex Pharmaceuticals Incorporated
- Jingrong Cao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of APOL1 and methods of using same
- Patent number 11,866,446
- Issue date Jan 9, 2024
- Vertex Pharmaceuticals Incorporated
- Jun Myun Ahn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of APOL1 and methods of using same
- Patent number 11,618,746
- Issue date Apr 4, 2023
- Vertex Pharmaceuticals Incorporated
- Jingrong Cao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazoles for the treatment of demyelinating dieases
- Patent number 10,766,869
- Issue date Sep 8, 2020
- VERTEX PHARMACEUTCALS INCORPORATED
- Robert J. Davies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoindolinone inhibitors of phosphatidylinositol 3-kinase
- Patent number 10,183,933
- Issue date Jan 22, 2019
- Vertex Pharmaceuticals Incorporated
- Alex Aronov
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazoles for the treatment of Demyelinating Diseases
- Patent number 10,118,904
- Issue date Nov 6, 2018
- Vertex Pharmaceuticals Incorporated
- Robert J. Davies
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoindolinone inhibitors of phosphatidylinositol 3-kinase
- Patent number 9,676,759
- Issue date Jun 13, 2017
- Vertex Pharmaceuticals Incorporated
- Alex Aronov
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Deazapurines useful as inhibitors of Janus kinases
- Patent number 8,741,912
- Issue date Jun 3, 2014
- Vertex Pharmaceuticals Incorporated
- Mark Ledeboer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoindolinone inhibitors of phosphatidylinositol 3-kinase
- Patent number 8,466,288
- Issue date Jun 18, 2013
- Vertex Pharmaceuticals Incorporated
- Alex Aronov
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azaindazoles useful as inhibitors of kinases
- Patent number 8,445,681
- Issue date May 21, 2013
- Vertex Pharmaceuticals Incorporated
- Guy Brenchley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of phosphatidylinositol 3-kinase
- Patent number 8,344,153
- Issue date Jan 1, 2013
- Vertex Pharmaceuticals Incorporated
- Kevin Michael Cottrell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
C-met protein kinase inhibitors
- Patent number 8,278,306
- Issue date Oct 2, 2012
- Vertex Pharmaceuticals Incorporated
- Jeremy Green
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CGRP receptor antagonists
- Patent number 8,163,737
- Issue date Apr 24, 2012
- Vertex Pharmaceuticals Incorporated
- Corey Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective inhibitors of rock protein kinase and uses thereof
- Patent number 8,058,271
- Issue date Nov 15, 2011
- Vertex Pharmaceuticals Incorporated
- Jeremy Green
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azaindazoles useful as inhibitors of kinases
- Patent number 8,017,781
- Issue date Sep 13, 2011
- Vertex Pharmaceuticals Incorporated
- Guy Brenchley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CGRP receptor antagonists
- Patent number 7,842,686
- Issue date Nov 30, 2010
- Vertex Pharmaceuticals Incorporated
- Corey Don Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CGRP receptor antagonists
- Patent number 7,834,000
- Issue date Nov 16, 2010
- Vertex Pharmaceuticals Incorporated
- Corey Gutierrez
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of c-JUN N-terminal kinases (JNK)
- Patent number 7,612,065
- Issue date Nov 3, 2009
- Vertex Pharmaceuticals Incorporated
- Jeremy Green
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azaindoles useful as inhibitors of rock and other protein kinases
- Patent number 7,514,448
- Issue date Apr 7, 2009
- Vertex Pharmaceuticals Incorporated
- Jeremy Green
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole compositions useful as inhibitors of ERK
- Patent number 7,354,919
- Issue date Apr 8, 2008
- Vertex Pharmaceuticals Incorporated
- Michael R. Hale
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic inhibitors of ERK2 and uses thereof
- Patent number 7,253,187
- Issue date Aug 7, 2007
- Vertex Pharmaceuticals Incorporated
- Jingrong Cao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases
- Patent number 7,169,798
- Issue date Jan 30, 2007
- Vertex Pharmaceuticals Incorporated
- Jeremy Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
- Patent number 7,084,159
- Issue date Aug 1, 2006
- Vertex Pharmaceuticals Incorporated
- Jingrong Cao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazole compositions useful as inhibitors of erk
- Patent number 7,056,944
- Issue date Jun 6, 2006
- Vertex Pharmaceuticals Incorporated
- Michael Hale
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazole compositions useful as inhibitors of ERK
- Patent number 6,784,195
- Issue date Aug 31, 2004
- Vertex Pharmaceuticals Incorporated
- Michael Hale
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic inhibitors of ERK2 and uses thereof
- Patent number 6,743,791
- Issue date Jun 1, 2004
- Vertex Pharmaceuticals Incorporated
- Jingrong Cao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazole compositions useful as inhibitors of ERK
- Patent number 6,699,865
- Issue date Mar 2, 2004
- Vertex Pharmaceuticals Incorporated
- Michael Hale
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of c-JUN N terminal kinases (JNK) and other protein kinases
- Patent number 6,693,108
- Issue date Feb 17, 2004
- Vertex Pharmaceuticals Incorporated
- Jeremy Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazole compositions useful as inhibitors of ERK
- Patent number 6,649,640
- Issue date Nov 18, 2003
- Vertex Pharmaceuticals Incorporated
- Michael Hale
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
INHIBITORS OF APOL1 AND METHODS OF USING SAME
- Publication number 20240368180
- Publication date Nov 7, 2024
- VERTEX PHARMACEUTICALS INCORPORATED
- Jun Myun AHN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF APOL1 AND METHODS OF USING SAME
- Publication number 20230271945
- Publication date Aug 31, 2023
- VERTEX PHARMACEUTICALS INCORPORATED
- Jingrong CAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF APOL1 AND METHODS OF USING SAME
- Publication number 20230014907
- Publication date Jan 19, 2023
- Vertex Pharmaceuticals Incorporated
- Leslie A. DAKIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF APOL1 AND METHODS OF USING SAME
- Publication number 20230011118
- Publication date Jan 12, 2023
- Vertex Pharmaceuticals Incorporated
- Leslie A. DAKIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF APOL1 AND METHODS OF USING SAME
- Publication number 20220340523
- Publication date Oct 27, 2022
- Vertex Pharmaceuticals Incorporated
- Leslie A. DAKIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF APOL1 AND METHODS OF USING SAME
- Publication number 20220106327
- Publication date Apr 7, 2022
- VERTEX PHARMACEUTICALS INCORPORATED
- Jun Myun AHN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF APOL1 AND METHODS OF USING SAME
- Publication number 20200377479
- Publication date Dec 3, 2020
- Vertex Pharmaceuticals Incorporated
- Jingrong CAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLES FOR THE TREATMENT OF DEMYELINATING DISEASES
- Publication number 20190185436
- Publication date Jun 20, 2019
- VERTEX PHARMACEUTICALS INCORPORATED
- Robert J. Davies
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE
- Publication number 20170260175
- Publication date Sep 14, 2017
- Vertex Pharmaceuticals Incorporated.
- Alex Aronov
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLES FOR THE TREATMENT OF DEMYELINATING DISEASES
- Publication number 20160355488
- Publication date Dec 8, 2016
- VERTEX PHARMACEUTICALS INCORPORATED
- Robert J. Davies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DEAZAPURINES USEFUL AS INHIBITORS OF JANUS KINASES
- Publication number 20140315931
- Publication date Oct 23, 2014
- VERTEX PHARMACEUTICALS INCORPORATED
- Mark Ledeboer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE
- Publication number 20140038936
- Publication date Feb 6, 2014
- Alex Aronov
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azaindazoles useful as inhibitors of kinases
- Publication number 20130310418
- Publication date Nov 21, 2013
- Vertex Pharmaceuticals Incorporated.
- Guy Brenchley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DEAZAPURINES USEFUL AS INHIBITORS OF JANUS KINASES
- Publication number 20120316186
- Publication date Dec 13, 2012
- Mark Ledeboer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE
- Publication number 20120202784
- Publication date Aug 9, 2012
- Vertex Pharmaceuticals Incorporated.
- Alex Aronov
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AZAINDAZOLES USEFUL AS INHIBITORS OF KINASES
- Publication number 20120165367
- Publication date Jun 28, 2012
- Guy Brenchley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
C-MET PROTEIN KINASE INHIBITORS
- Publication number 20120065213
- Publication date Mar 15, 2012
- Vertex Pharmaceuticals Incorporated.
- Jeremy Green
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE
- Publication number 20120040950
- Publication date Feb 16, 2012
- Vertex Pharmaceuticals Incorporated.
- Alex Aronov
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DEAZAPURINES USEFUL AS INHIBITORS OF JANUS KINASES
- Publication number 20090227607
- Publication date Sep 10, 2009
- Mark Ledeboer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CGRP RECEPTOR ANTAGONISTS
- Publication number 20090176769
- Publication date Jul 9, 2009
- Corey Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Deazapurines useful as inhibitors of Janus kinases
- Publication number 20090088445
- Publication date Apr 2, 2009
- Mark Ledeboer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of c-Jun N-terminal kinases (JNK)
- Publication number 20080033022
- Publication date Feb 7, 2008
- Francesco G. Salituro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CGRP receptor antagonists
- Publication number 20080004261
- Publication date Jan 3, 2008
- Corey Gutierrez
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Selective inhibitors of rock protein kinase and uses thereof
- Publication number 20070270386
- Publication date Nov 22, 2007
- Jeremy Green
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic inhibitors of ERK2 and uses thereof
- Publication number 20070265263
- Publication date Nov 15, 2007
- Jingrong Cao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azaindazoles useful as inhibitors of kinases
- Publication number 20070179177
- Publication date Aug 2, 2007
- Guy Brenchley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclic inhibitors of Rho kinase
- Publication number 20060122185
- Publication date Jun 8, 2006
- Jeremy Green
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azaindoles useful as inhibitors of rock and other protein kinases
- Publication number 20060003968
- Publication date Jan 5, 2006
- Jeremy Green
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isoxazole compositions useful as inhibitors of ERK
- Publication number 20050090536
- Publication date Apr 28, 2005
- Michael R. Hale
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of c-jun N terminal kinases (JNK) and other protein kinases
- Publication number 20050026967
- Publication date Feb 3, 2005
- Jeremy Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Jingrong Cao

Person

Patents Grantslast 30 patents

Inhibitors of APOL1 and methods of using same

Inhibitors of APOL1 and methods of using same

Inhibitors of APOL1 and methods of using same

Inhibitors of APOL1 and methods of using same

Triazoles for the treatment of demyelinating dieases

Isoindolinone inhibitors of phosphatidylinositol 3-kinase

Triazoles for the treatment of Demyelinating Diseases

Isoindolinone inhibitors of phosphatidylinositol 3-kinase

Deazapurines useful as inhibitors of Janus kinases

Isoindolinone inhibitors of phosphatidylinositol 3-kinase

Azaindazoles useful as inhibitors of kinases

Inhibitors of phosphatidylinositol 3-kinase

C-met protein kinase inhibitors

CGRP receptor antagonists

Selective inhibitors of rock protein kinase and uses thereof

Azaindazoles useful as inhibitors of kinases

CGRP receptor antagonists

CGRP receptor antagonists

Inhibitors of c-JUN N-terminal kinases (JNK)

Azaindoles useful as inhibitors of rock and other protein kinases

Isoxazole compositions useful as inhibitors of ERK

Heterocyclic inhibitors of ERK2 and uses thereof

Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases

Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases

Pyrazole compositions useful as inhibitors of erk

Pyrazole compositions useful as inhibitors of ERK

Heterocyclic inhibitors of ERK2 and uses thereof

Pyrazole compositions useful as inhibitors of ERK

Inhibitors of c-JUN N terminal kinases (JNK) and other protein kinases

Isoxazole compositions useful as inhibitors of ERK

Patents Applicationslast 30 patents

INHIBITORS OF APOL1 AND METHODS OF USING SAME

INHIBITORS OF APOL1 AND METHODS OF USING SAME

INHIBITORS OF APOL1 AND METHODS OF USING SAME

INHIBITORS OF APOL1 AND METHODS OF USING SAME

INHIBITORS OF APOL1 AND METHODS OF USING SAME

INHIBITORS OF APOL1 AND METHODS OF USING SAME

INHIBITORS OF APOL1 AND METHODS OF USING SAME

TRIAZOLES FOR THE TREATMENT OF DEMYELINATING DISEASES

ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE

TRIAZOLES FOR THE TREATMENT OF DEMYELINATING DISEASES

DEAZAPURINES USEFUL AS INHIBITORS OF JANUS KINASES

ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE

Azaindazoles useful as inhibitors of kinases

DEAZAPURINES USEFUL AS INHIBITORS OF JANUS KINASES

ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE

AZAINDAZOLES USEFUL AS INHIBITORS OF KINASES

C-MET PROTEIN KINASE INHIBITORS

ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE

DEAZAPURINES USEFUL AS INHIBITORS OF JANUS KINASES

CGRP RECEPTOR ANTAGONISTS

Deazapurines useful as inhibitors of Janus kinases

Inhibitors of c-Jun N-terminal kinases (JNK)

CGRP receptor antagonists

Selective inhibitors of rock protein kinase and uses thereof

Heterocyclic inhibitors of ERK2 and uses thereof

Azaindazoles useful as inhibitors of kinases

Bicyclic inhibitors of Rho kinase

Azaindoles useful as inhibitors of rock and other protein kinases

Isoxazole compositions useful as inhibitors of ERK

Inhibitors of c-jun N terminal kinases (JNK) and other protein kinases